ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Ironwood Pharmaceuticals Initiates Pivotal Phase III Program for IW-3718 in Persistent Gastroesophageal Reflux Disease
June 27, 2018Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a commercial biotech company, today announced the initiation of two Phase III clinical trials evaluating the safety and efficacy of IW-3718 in patients with persistent gastroesophageal reflux disease (GERD). -
Phase III success for Janssen’s esketamine in treatment-resistant depression
June 21, 2018Janssen has presented data from pivotal Phase III clinical studies backing use of esketamine spray in treatment-resistant depression. -
Update on Phase III clinical trials of lanabecestat for Alzheimer's disease
June 20, 2018AstraZeneca and Eli Lilly and Company (Lilly) are discontinuing the global Phase III clinical trials of lanabecestat, an oral beta secretase cleaving enzyme (BACE) inhibitor -
Merck announces findings from Phase III study of KEYTRUDA
September 14, 2017The findings include updated survival data showing a 19 per cent reduction in the risk of death over standard treatment in the intent-to-treat population -
RedHill Biopharma announces successful Phase III
July 04, 2017RedHill Biopharma announces successful Phase III top-line results with BEKINDA for Acute Gastroenteritis.
Pharma Sources Insight January 2025
